LAVA Therapeutics (NASDAQ:LVTX) Short Interest Update

LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 211,600 shares, a drop of 34.3% from the March 15th total of 322,100 shares. Currently, 1.5% of the company’s stock are sold short. Based on an average daily volume of […]

Related Keywords

United States ,America , ,Financial Services Group Inc ,Renaissance Technologies ,Citadel Advisors ,Pathway Financial Advisors ,Nasdaq ,America Corp ,Get Free Report ,Financial Advisors ,Services Group ,Lava Therapeutics ,Nasdaq Lvtx ,Lvtx ,Medical ,Stocks ,Options ,Put ,Call ,